SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-14-000663
Filing Date
2014-03-31
Accepted
2014-03-31 16:33:20
Documents
8
Period of Report
2014-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e612085_8k-retrophin.htm 8-K 41632
2 e612085_ex10-1.htm EX-10.1 80681
3 e612085_ex10-2.htm EX-10.2 489813
4 e612085_ex10-3.htm EX-10.3 35910
5 e612085_ex10-4.htm EX-10.4 57105
6 e612085_ex10-5.htm EX-10.5 53160
7 e612085_ex99-1.htm EX-99.1 12142
8 GRAPHIC logo.jpg GRAPHIC 2697
  Complete submission text file 0001193805-14-000663.txt   775643
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 14730516
SIC: 2834 Pharmaceutical Preparations